Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

1,019.49
+8.380.83%
Post-market: 1,019.490.00000.00%16:15 EDT
Volume:142.23K
Turnover:145.28M
Market Cap:63.76B
PE:38.89
High:1,030.36
Open:1,020.29
Low:1,013.75
Close:1,011.11
52wk High:1,058.69
52wk Low:661.85
Shares:62.54M
Float Shares:62.45M
Volume Ratio:0.42
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.57
PE(LYR):52.09

Loading ...

Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results

TIPRANKS
·
Aug 17

Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023

Dow Jones
·
Aug 17

Argenx rises 14.9%

TIPRANKS
·
Aug 17

Movement Alert|Argenx SE Rises 9.45% in Regular Trading, Phase 3 Trial of Efgartigimod in Autoimmune Myositis Meets Primary Endpoint

Market Focus
·
Aug 17

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Lower Rate Hike Expectations

MT Newswires Live
·
Aug 17

Sector Update: Healthcare

MT Newswires Live
·
Aug 17

Argenx price target raised to $1,215 from $1,075 at Piper Sandler

TIPRANKS
·
Aug 17

Movement Alert|Argenx SE Rises 5% in Pre-Market Trading, Phase 3 Trial of Efgartigimod in Autoimmune Myositis Meets Primary Endpoint

Market Focus
·
Aug 17

argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study

MT Newswires Live
·
Aug 17

Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod

Dow Jones
·
Aug 17

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live
·
Aug 14

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

TIPRANKS
·
Aug 14

Argenx resumed with a Buy at Guggenheim

TIPRANKS
·
Aug 05

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Argenx Se (ARGX)

TIPRANKS
·
Jul 29

Argenx is Maintained at Outperform by Wedbush

Dow Jones
·
Jul 28

Argenx price target raised to $1,050 from $1,000 at Wedbush

TIPRANKS
·
Jul 28

Argenx Se : Wedbush Raises Target Price to $1050 from $1000

THOMSON REUTERS
·
Jul 28

Forte Biosciences downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Jul 28